Safety and efficacy of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune disease: A systematic review and meta-analysis in non-small cell lung cancer

被引：0
|
作者：
Aung, Wint Yan
Lee, Chung-Shien
Morales, Jaclyn
Kohn, Nina
Rahman, Husneara
Seetharamu, Nagashree
机构：
[1] Northwell Hlth, Manhasset, NY USA
[2] Northwell Hlth Canc Inst, New Hyde Pk, NY USA
[3] Feinstein Inst Med Res, Manhasset, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9053
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of angiogenesis inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis
    Shaodong Hong
    Min Tan
    Shouzheng Wang
    Shengyuan Luo
    Yue Chen
    Li Zhang
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 909 - 921
  • [32] Efficacy and safety of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC): a systematic literature review
    Wagner, Gernot
    Stollenwerk, Hannah Karolina
    Klerings, Irma
    Pecherstorfer, Martin
    Gartlehner, Gerald
    Singer, Josef
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [33] Safety and efficacy of immune checkpoint inhibitors in advanced cancer patients with autoimmune disease: A meta-analysis
    Cai, Qi
    Huo, Geng-wei
    Zhu, Fu-yi
    Yue, Ping
    Yuan, Dong-qi
    Chen, Peng
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022,
  • [34] The efficacy and safety of immune-checkpoint inhibitors plus chemotherapy versus chemotherapy for non-small cell lung cancer: An updated systematic review and meta-analysis
    Kang, Jing
    Zhang, Jun
    Tian, Zongsheng
    Xu, Ye
    Li, Jiangbi
    Li, Mingxian
    PLOS ONE, 2024, 19 (02):
  • [35] Comparative efficacy and safety of first-line treatments for advanced non-small cell lung cancer with immune checkpoint inhibitors: A systematic review and meta-analysis
    Chen, Rui
    Hou, Xiaoming
    Yang, Liping
    Zhao, Da
    THORACIC CANCER, 2019, 10 (04) : 607 - 623
  • [36] Immune Checkpoint Inhibitors with or without Radiotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Systematic Review and Meta-Analysis
    Kim, Dong Yeong
    Kim, Pyeong Hwa
    Suh, Chong Hyun
    Kim, Kyung Won
    Kim, Ho Sung
    DIAGNOSTICS, 2020, 10 (12)
  • [37] Incidence of thromboembolic events in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
    Yang, Miaomiao
    Cao, Hongxin
    Wang, Congcong
    Yu, Caiyan
    Sun, Ping
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (02) : 509 - 521
  • [38] Efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients with different metastatic sites: A systematic review and meta-analysis.
    Yang, Kaili
    Zhao, Lin
    Li, Jiarui
    Bai, Chunmei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non-Small Cell Lung Cancer and Melanoma: Network Meta-Analysis and Systematic Review
    Chai, Qing-Qing
    Du, Jiang-Yang
    Zhu, Jun
    Wu, Bin
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [40] Association of clinical and molecular factors with immune checkpoint inhibitors efficacy in advanced non-small cell lung cancer:A systematic review and meta-analysis
    Li, F.
    Lv, Z.
    Mao, Y.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1054 - S1054
12345